Title: A Novel Method of measuring metamorphopsia in macular diseases using computerised D charts

Authors: Dr Hema M Mer, Dr Ajay Dudani, Prof. Niall Strang, Dr Sven Jonuscheit

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i9.112

Abstract

Purpose: This study examines the ability of the computerised D chart to detect and quantify metamorphosis in different macular disorders and compare the results with other clinical measurements such as visual acuity, Amsler chart and Optical Coherence Tomography (OCT).

Methodology: A software version of D charts uses octagonal grids with varying eccentricities from 0.5 to 12 degrees from fixation. Subjects do fixation by focussing at the centre of the D-charts and locate the area of distortion by touching the screen. The sector was highlighted by a blue line and later the software determines MScore, Mtotal, Marea for each ring. D Chart measures were undertaken on 30 subjects and the results were compared to LogMAR visual acuity, Amsler chart and OCT.

Results: Computerised D-Chart is easy to use and there was no correlation between MScore and VA, MScore and CSF (p>0.05). There was a correlation between MScore and Amsler. (r=0.806 p=0.000163). Both cases showed similarities in the structural and functional details of metamorphopsia.

Conclusion: D charts allowed quantification of metamorphopsia in macular disease patients with variable visual acuities. It is one of the most important diagnostic tools to map distortion and central field loss and may be helpful in assessing ongoing macular diseases.

References

  1. AMSLER, , 1953. Earliest symptoms of diseases of the macula. The British Journal  of   Ophthalmology.   37(9),   pp.   521-537.   Available   from:   DOI 10.1136/bjo.37.9.521.
  2. BAE, , JIN, K., KIM, H. and BAE, S.H., 2015. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study. BMC Ophthalmology. 15 pp. 180.
  3. BAE, and CHAE, J., 2013. Assessment of metamorphopsia in patients with central serous chorioretinopathy. Indian Journal of Ophthalmology. 61(4), pp.172-5.
  4. BAE, H.,  et  al.,  2013.  Preferential  hyperacuity  perimeter  and  prognostic factors for metamorphopsia after idiopathic epiretinal membrane surgery. American Journal of Ophthalmology. 155(1), pp. 109-117.e3. Available from: DOI 10.1016/j.ajo.2012.07.007.
  5. KRASNICKI, P., et , 2015. Metamorphopsia before and after full-thickness macular hole surgery. Advances in Medical Sciences. 60(1), pp. 162-166.
  6. LOEWENSTEIN, , et al., 2003. Replacing the Amsler grid: a new method for monitoring  patients     with age-related macular degeneration Ophthalmology. 110(5), pp. 966.
  7. LOWRY, ,   1998-2016.    Vassar Stats Website     for     Statistical Computation Available from:
  8. Lund Research   Ltd,              Laerd Statistics Available from: https://statistics.laerd.com/spss-tutorials/spearmans-rank-order- correlation-using-spss-statistics.p  hp.
  9. MANABE, , et al., 2016. Metamorphopsia Associated with Branch Retinal Vein Occlusion. PLoS One. 11(4), pp. n/a.
  10. MATSUMOTO, , et al., 2003. Quantification of Metamorphopsia in Patients with Epiretinal Membranes. Investigative Ophthalmology & Visual Science.44(9), pp. 4012. Available from: DOI 10.1167/iovs.03-0117.
  11. MCGOWAN, ,  YORSTON,  D.,  STRANG,  N.C.  and  MANAHILOV,  V.,2016.  D-CHART:  A  Novel  Method  of  Measuring  Metamorphopsia   in Epiretinal Membrane and Macular Hole. Retina (Philadelphia, Pa.). 36(4), pp. 703-708.
  12. MIDENA, and VUJOSEVIC, S., 2015. Metamorphopsia: An Overlooked Visual Symptom. Ophthalmic Research. 55(1), pp. 26-36.
  13. OKAMOTO, F., et , 2012. Associations between metamorphopsia and foveal microstructure in patients with epiretinal membrane. Investigative Ophthalmology & Visual Science. 53(11), pp. 6770-6775.
  14. OKAMOTO,  F.,   et   ,   2014.   Metamorphopsia  and   optical   coherence tomography findings after rhegmatogen-ous retinal detachment surgery. American Journal of Ophthalmology. 157(1), pp. 214. Available from: DOI 10.1016/j.ajo.2013.08.007.
  15. OKAMOTO, Y.,  OKAMOTO,  F.,  HIRAOKA,  T.  and  OSHIKA,  T.,   Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy. Japanese Journal of Ophthalmology. 58(4), pp. 369-74.
  16. ROSSETTI, , DORO, D., MANFRÈ, A. and MIDENA, E., 2010. Long-term follow-up with optical coherence  tomography  and microperimetry  in eyes with metamorphopsia after macula-off retinal detachment repair. Eye. 24(12), pp. 1808-1813. Available from: DOI 10.1038/eye.2010.138.
  17. SCHWARTZ, and LOEWENSTEIN, A., 2015. Early detection of age related macular degeneration: current status. International Journal of Retina and Vitreous. 1 pp. n/a.
  18. STRANG, ,  2016.  Measuring  metamorphopsia  using  the  D-Chart  test. London: Mark Allen Publishing Ltd
  19. THOMPSON SOFTWARE  SOLUTION,    The  D  charts  Thompson software solution.Available from: http://www.thomson-software- solutions.com/d-chart/
  20. UGARTE, and WILLIAMSON, T.H., 2010. "Metamorphopsia" assessment. Investigative Ophthalmology & Visual Science. 51(12), pp. 6894-5; author reply 6895.
  21. UGARTE, , SHUNMUGAM, M., LAIDLAW, D. and WILLIAMSON, T., 2013. Morphision: A method for subjective evaluation of metamorphopsia in patients with unilateral macular pathology (i.e., full thickness macular hole and epiretinal membrane). Indian Journal of Ophthalmology. 61(11), pp. 653-8.
  22. WIECEK, , DAKIN, S.C. and BEX, P., 2014. Metamorphopsia and letter recognition. Journal  of  Vision.  14(14),  pp.  1-1.  Available  from:  DOI 10.1167/14.14.1.

Corresponding Author

Dr Hema M Mer

Glasgow Caledonian University & Mumbai Retina Centre

Mobile Number: 8369288039